-

Mayfield Raises $955 Million Across Two New Funds Dedicated to Early Stage Investing

MENLO PARK, Calif.--(BUSINESS WIRE)--Mayfield, a top-tier early stage investor, today announced that it has raised a total of $955 million across two venture capital funds to continue its focus on being a champion of entrepreneurs.

The $580 million Mayfield XVII and the $375 million Mayfield Select III follow the $750 million raised by prior funds in March 2020, bringing the Firm’s total assets under management to $3 billion. Both funds became oversubscribed in a couple of weeks.

Mayfield XVII will continue the Firm’s early stage focus, primarily investing in companies at the inception or early customer adoption stage (Seed and Series A rounds). Mayfield Select III (aka Mayfield Spring) will invest in follow-on rounds of breakout portfolio companies and new companies (primarily at the Series B round) from outside its portfolio.

The Firm invests in companies that leverage innovation in both IT and biology. Some themes include human-centered AI, the data economy, the developer-first era, the renaissance of semiconductors, cybersecurity, deeptech, Web3, and human and planetary health.

The investing team is led by Managing Partner Navin Chaddha and team members include Rajeev Batra, Arvind Gupta, Tejas Maniar, Ursheet Parikh and Patrick Salyer.

“We are grateful for the continued support of our limited partners and for the fortitude of entrepreneurs which brings us to work every day,” said Chaddha. “We believe that the current economic uncertainty presents an opportunity for the bold and a time to lean forward into the next era of innovation. We are excited about partnering with inception and early stage founders looking for a People-First investor to build a bright future together.”

About Mayfield

Mayfield is an early stage venture capital firm with a people-first philosophy and $3 billion under management. The Firm has a proven track record of partnering with founders starting at the inception stage to help build iconic enterprise, AI-first, deeptech and human and planetary health companies. The Firm has invested in more than 550 companies, resulting in 120 IPOs and more than 225 acquisitions. Some recent notable investments include HashiCorp, Lyft, Poshmark/Naver, Mammoth Biosciences, Marketo/Adobe, NUVIA/Qualcomm, Outreach, Rancher/SUSE, SolarCity/Tesla and Volterra/F5. For more information, go to https://www.mayfield.com or follow @MayfieldFund.

Contacts

Kamini Ramani kramani@mayfield.com

Mayfield


Release Versions

Contacts

Kamini Ramani kramani@mayfield.com

Social Media Profiles
More News From Mayfield

Mayfield Adds New Investor Sri Pangulur As First Dedicated Select/Spring Fund Partner

MENLO PARK, Calif.--(BUSINESS WIRE)--Mayfield today announced that Sri Pangulur, a proven enterprise investor and operating leader, will join the team as the first dedicated partner to focus on investing out of the firm’s Select/Spring funds which invest in new companies (primarily at the Series B round) from outside its portfolio and follow-on rounds of existing breakout portfolio companies. This brings the investing team to eight partners, along with the founder amplification team of four ope...

Mayfield Announces $250 Million AI Start Seed Fund and Adds New Partner

MENLO PARK, Calif.--(BUSINESS WIRE)--Mayfield, a top-tier early-stage venture capital firm, today announced the $250 million AI Start, the first seed fund in its history, to partner with AI-first founders starting at Day Zero. The Firm also added Vijay Reddy, an AI-focused investor with a decade of successful seed stage experience, as a dedicated AI Start Seed Fund partner. “We believe that AI will emerge as our teammate and that the Gen.AI wave will create many iconic companies,” said Navin Ch...

New Partner Arvind Gupta & Genesis Consortium Reflect Mayfield’s Commitment to Human and Planetary Evolution

MENLO PARK, Calif.--(BUSINESS WIRE)--Mayfield today announced the addition of Arvind Gupta, founder of the world’s leading biotech accelerator IndieBio, as Partner to expand the firm’s vibrant engineering biology practice. The firm also announced that it had invested in and partnered with SOSV, the parent firm of IndieBio, to co-found the Genesis Consortium, an alliance of funds and corporations to promote human and planetary evolution. Gupta will continue as Venture Advisor at IndieBio and adv...
Back to Newsroom